News tagged with tuberculosis
Management of TB cases falls short of international standards
The management of tuberculosis cases in the European Union (EU) is not meeting international standards, according to new research.
Feb 09, 2012 |
not rated yet |
0
'Goldilocks' gene could determine best treatment for tuberculosis patients
Tuberculosis patients may receive treatments in the future according to what version they have of a single 'Goldilocks' gene, says an international research team from Oxford University, King's College London, Vietnam and ...
Feb 02, 2012 |
5 / 5 (1) |
0
|
Portable device will quickly detect pathogens
(PhysOrg.com) -- Two Cornell professors will combine their inventions to develop a handheld pathogen detector that will give health care workers in the developing world speedy results to identify in the field ...
Jan 31, 2012 |
not rated yet |
0
MSU technology spin-out company to market portable biohazard detection
A new company formed around Michigan State University nanotechnology promises to move speedy detection of deadly pathogens and toxins from the laboratory directly to the field.
Chemistry / Analytical Chemistry
Jan 27, 2012 |
5 / 5 (1) |
0
Indian experts probing 'untreatable' TB cases
The Indian government on Tuesday dispatched a team of medical experts to the financial capital, Mumbai, to assess reports of a handful of cases of apparently untreatable tuberculosis.
Jan 17, 2012 |
not rated yet |
0
Ukraine urged to step up AIDS fight
(AP) -- The head of a global health fund on Monday urged Ukraine to step up its efforts to fight the HIV/AIDS epidemic, Europe's largest.
Medicine & Health / HIV & AIDS
Jan 16, 2012 |
not rated yet |
1
India reports new TB strain resistant to all drugs
Indian doctors have reported the country's first cases of "totally drug-resistant tuberculosis," a long-feared and virtually untreatable form of the killer lung disease.
Jan 16, 2012 |
5 / 5 (3) |
1
Study suggests new way to ensure effectiveness of TB treatment
A UT Southwestern Medical Center study using a sophisticated "glass mouse" research model has found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent ...
Dec 28, 2011 |
not rated yet |
0
|
Chemistry trick renews hope against killer diseases
As infections such as tuberculosis have become immune to an ever widening range of antibiotics doctors have looked on helplessly.
Dec 28, 2011 |
5 / 5 (6) |
1
Could cod liver oil help combat tuberculosis?
A review of a historical study from 1848 reveals that cod liver oil was an effective treatment for tuberculosis, says Professor Sir Malcolm Green in the Christmas issue published on in the British Medical Journal today.
Dec 20, 2011 |
5 / 5 (1) |
0
Scientists develop animal model for TB-related blindness
(Medical Xpress) -- Working with guinea pigs, tuberculosis experts at Johns Hopkins and elsewhere have closely mimicked how active but untreated cases of the underlying lung infection lead to permanent eye damage and blindness ...
Dec 16, 2011 |
not rated yet |
0
Vanderbilt study leads to simpler therapy for treating latent tuberculosis
Research, led by Timothy Sterling, M.D., professor of Medicine at Vanderbilt University Medical Center, has led to an important change in CDC recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis ...
Dec 09, 2011 |
not rated yet |
0
Discordance among commercially-available diagnostics for latent TB infection
In populations with a low prevalence of tuberculosis (TB), the majority of positives with the three tests commercially available in the U.S for the diagnosis of TB are false positives, according to a new study.
Dec 09, 2011 |
not rated yet |
0
US urges shorter treatment for TB
US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.
Dec 08, 2011 |
not rated yet |
0
Vaccine targeting latent TB enters clinical testing
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The ...
Medicine & Health / Medications
Dec 01, 2011 |
not rated yet |
0
Tuberculosis
Tuberculosis (abbreviated as TB for tubercle bacillus or Tuberculosis) is a common and often deadly infectious disease caused by mycobacteria, in humans mainly Mycobacterium tuberculosis . Tuberculosis usually attacks the lungs (as pulmonary TB) but can also affect the central nervous system, the lymphatic system, the circulatory system, the genitourinary system, the gastrointestinal system, bones, joints, and even the skin. Other mycobacteria such as Mycobacterium bovis, Mycobacterium africanum, Mycobacterium canetti, and Mycobacterium microti also cause tuberculosis, but these species are less common in humans.
The classic symptoms of tuberculosis are a chronic cough with blood-tinged sputum, fever, night sweats, and weight loss. Infection of other organs causes a wide range of symptoms. The diagnosis relies on radiology (commonly chest X-rays), a tuberculin skin test, blood tests, as well as microscopic examination and microbiological culture of bodily fluids. Tuberculosis treatment is difficult and requires long courses of multiple antibiotics. Contacts are also screened and treated if necessary. Antibiotic resistance is a growing problem in (extensively) multi-drug-resistant tuberculosis. Prevention relies on screening programs and vaccination, usually with Bacillus Calmette-Guérin (BCG vaccine).
Tuberculosis is spread through the air, when people who have the disease cough, sneeze, or spit. One–third of the world's current population has been infected with M. tuberculosis, and new infections occur at a rate of one per second. However, most of these cases will not develop the full-blown disease; asymptomatic, latent infection is most common. About one in ten of these latent infections will eventually progress to active disease, which, if left untreated, kills more than half of its victims. The proportion of people in the general population who become sick with tuberculosis each year is stable or falling worldwide but, because of population growth, the absolute number of new cases is still increasing. In 2004, mortality and morbidity statistics included 14.6 million chronic active cases, 8.9 million new cases, and 1.6 million deaths, mostly in developing countries. In addition, a rising number of people in the developed world are contracting tuberculosis because their immune systems are compromised by immunosuppressive drugs, substance abuse, or AIDS. The distribution of tuberculosis is not uniform across the globe with about 80% of the population in many Asian and African countries testing positive in tuberculin tests, while only 5-10% of the US population test positive. It is estimated that the US has 25,000 new cases of tuberculosis each year, 40% of which occur in immigrants from countries where tuberculosis is endemic.
For more information about Tuberculosis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.